Are you healthy and looking to help advance medical science?

You may be eligible to participate in a neurofibromatosis type 1 clinical study, and could be compensated for your time.

Are you healthy and looking to help advance medical science? You may be eligible to participate in a neurofibromatosis type 1 clinical study, and could be compensated for your time.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Neurofibromatosis Type 1 Clinical Trial in Nashville TN
NCT02964884 | Phase 2 | Interventional

Are you healthy and looking to help advance medical science?

You may be eligible to participate in a neurofibromatosis type 1 clinical study, and could be compensated for your time.

Are you healthy and looking to help advance medical science? You may be eligible to participate in a neurofibromatosis type 1 clinical study, and could be compensated for your time.

Recruiting

Male & Female

8 - 20

Years old

This study is looking to recruit 120 Participants

Neurofibromatosis Type 1 (NF1) is a common genetic disorder that is associated with a four times greater risk of learning disabilities, including reading disabilities, and a deficiency of neurofibromin - a protein important in a signaling pathway that regulates learning and memory. Our previous work (NS49096) demonstrated that school-age children with NF+RD can respond to standard phonologically-based reading tutoring originally developed to treat reading disability in the general population. Combining our work with that by other researchers suggesting that a medication (Lovastatin) may counteract the effects of the deficient neurofibromin, and possibly ameliorate learning disabilities in NF1, the investigator propose to examine the synergistic effects of medication plus reading tutoring.